Papillomas at high risk for malignant progression arising both early and late during two-stage carcinogenesis in SENCAR mice
Open Access
- 1 June 1998
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 19 (6) , 1141-1147
Abstract
The current study was designed to further establish that most papillomas produced in SENCAR mice during two-stage skin carcinogenesis are, in fact, premalignant lesions and to specifically determine the malignant conversion potential of papillomas that arise at different times during the carcinogenesis process. A method was established to physically map and monitor the lifespan of all papillomas produced in SENCAR mice during the course of an initiation-promotion experiment using DMBA as the initiator and 12-O-tetradecanoylphorbol-13-acetate (TPA) as the promoter. The results from these experiments showed that in groups of mice initiated with either 0.5 or 2.0 microg DMBA, long-term (60 weeks) treatment with TPA yielded a significantly higher number of SCCs compared to short-term treatment (7 weeks). Papillomas that emerged after 11 weeks and thereafter in all treatment groups had the ability to progress to SCCs. The median conversion time for all papillomas in all groups was 26 weeks. When corrected for median conversion time, papillomas that emerged in week 11 and thereafter in all treatment groups had similar or greater conversion ratios compared to those that emerged within the first 10 weeks. Interestingly, the median conversion time was significantly shorter (18 versus 27 weeks, respectively; P11 weeks) progressed to SCCs at a faster rate than those that arose earliest in the protocol.Keywords
This publication has 9 references indexed in Scilit:
- CANCER BIOLOGY: Regression and progression characteristics of papillomas induced by chrysarobin in SENCAR miceCarcinogenesis, 1996
- Malignant progression of papillomas induced by the initiation-promotion protocol in NMRI mouse skinCarcinogenesis, 1995
- Further studies on the influence of initiation dose on papilloma growth and progression during two-stage carcinogenesis in SENCAR miceCarcinogenesis, 1993
- Multistage carcinogenesis in mouse skinPharmacology & Therapeutics, 1992
- Further Characterization of Skin Tumor Promotion and Progession by Mezerein in SENCAR MiceJNCI: Journal of the National Cancer Institute, 1989
- Progressive dysplasia and aneuploidy are hallmarks of mouse skin papillomas: relevance to malignancy.Proceedings of the National Academy of Sciences, 1987
- Induction of papillomas with a high probability of conversion to malignancyCarcinogenesis, 1985
- Skin Tumor-Promoting Activity of Benzoyl Peroxide, a Widely Used Free Radical-Generating CompoundScience, 1981
- The Sequential Analysis of Cancer Development1980